Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Medical Affairs Consortium Research Identifies Winning Strategies for Successful Thought Leader Management

CHAPEL HILL, N.C., April 18, 2014 /PRNewswire/ --In today's highly competitive and demanding healthcare landscape, pharmaceutical, biotechnology and medical device companies greatly rely on thought leaders to influence the important decisions relevant to their products. Thought leaders are the bellwethers of market direction, as they help companies to better understand where therapeutic guidelines and practices are headed and they influence how practicing physicians respond to new therapies. The third round of research from the Best Practices' 2013-2014 Medical Affairs Consortium identifies winning strategies, tactics and insights for successful thought leader management. The research has focused on:

  • Leadership within the thought leader management function
  • Functional oversight of thought leader management
  • Strategies for developing and maintaining relationships with thought leaders
  • Operations of thought leader management teams
  • Effective communications channels
  • New technologies
  • Innovative strategies to overcome regulatory challenges

The third round of research from the Best Practices' 2013-2014 Medical Affairs Consortium provides leaders with an evidence-based understanding of current and evolving approaches to thought leader management. This benchmarking research drew participation from 40 Medical Affairs leaders at 32 biopharma and device organizations. In addition, secondary research was conducted within Best Practices LLC's database to gather additional insights.

For more information regarding the Medical Affairs Consortium studies, please review Weekly Medical Affairs Consortium Research Release.

To learn more about Medical Affairs Consortium, click on the following link:http://www.best-in-class.com/medical-affairs-consortium

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website athttp://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.